BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11702604)

  • 1. MDS and secondary AML: an evolutionary perspective.
    Audeh MW
    Cancer Treat Res; 2001; 108():267-78. PubMed ID: 11702604
    [No Abstract]   [Full Text] [Related]  

  • 2. Evolution of secondary hematologic disorders: preMDS-->MDS-->sAML.
    Preisler HD
    Cancer Treat Res; 2001; 108():185-230. PubMed ID: 11702600
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular, cytogenetic and genetic abnormalities in MDS and secondary AML.
    Padua RA; McGlynn A; McGlynn H
    Cancer Treat Res; 2001; 108():111-57. PubMed ID: 11702597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myelodysplastic syndromes: preleukemic syndromes].
    Tassin F; Hermanne JP; Schaaf-Lafontaine N; Herens C; Thiry A; Paulus JM; Boniver J; Fillet G
    Rev Med Liege; 1998 Jun; 53(6):357-62. PubMed ID: 9713217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of the farnesyl transferase inhibitor FTI L-778,123 on normal, myelodysplastic, and myeloid leukemia bone marrow progenitor proliferation in vitro.
    Huang XK; Meyer P; Li B; Raza A; Preisler HD
    Leuk Lymphoma; 2003 Jan; 44(1):157-64. PubMed ID: 12691158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelodysplastic syndromes (preleukemia).
    Koeffler HP
    Semin Hematol; 1986 Oct; 23(4):284-99. PubMed ID: 3535083
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene rearrangements in bone marrow cells of patients with acute myelogenous leukemia.
    Schmetzer HM; Braun S; Wiesner D; Duell T; Gerhartz HH; Mittermueller J
    Acta Haematol; 2000; 103(3):125-34. PubMed ID: 10940650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C/EBP-epsilon: chromosomal mapping and mutational analysis of the gene in leukemia and preleukemia.
    Koike M; Chumakov AM; Takeuchi S; Tasaka T; Yang R; Nakamaki T; Tsuruoka N; Koeffler HP
    Leuk Res; 1997 Sep; 21(9):833-9. PubMed ID: 9393598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelodysplastic syndromes complicating hematopoietic stem cell transplantation.
    Fassas AB; Tricot G
    Cancer Treat Res; 2001; 108():169-84. PubMed ID: 11702599
    [No Abstract]   [Full Text] [Related]  

  • 10. inv(3)(q21q26) in AML/MDS: Monitoring of the malignant clone with interphase FISH.
    Schmidt HH; Pirc-Danoewinata H; Linkesch W; Strunk D; Wieser R
    Haematologica; 2003 Dec; 88(12):ECR38. PubMed ID: 14688011
    [No Abstract]   [Full Text] [Related]  

  • 11. Trisomy 4 and ring chromosome in a patient with acute myelomonocytic leukemia.
    Vicari L; Sebastio L; Stanziola MC; Fasanaro A; Ferrara F
    Haematologica; 1994; 79(1):83-5. PubMed ID: 15378955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving concepts in myelodysplastic syndromes.
    Raza A
    Cancer Treat Res; 2001; 108():1-24. PubMed ID: 11702595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preleukemia: one name, many meanings.
    Koeffler HP; Leong G
    Leukemia; 2017 Mar; 31(3):534-542. PubMed ID: 27899806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-cycle progression rates and sister chromatid exchange frequencies in the bone marrow of patients with myelodysplastic syndrome and acute myeloid leukemia.
    Jones BM; White AD; Culligan DJ; Jacobs A
    Cancer Genet Cytogenet; 1992 Aug; 62(1):66-9. PubMed ID: 1521237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis in MDS: a new perspective.
    Mundle SD
    Cancer Treat Res; 2001; 108():101-9. PubMed ID: 11702596
    [No Abstract]   [Full Text] [Related]  

  • 16. Selective pressure as an essential force in molecular evolution of myeloid leukemic clones: a view from the window of Fanconi anemia.
    Lensch MW; Rathbun RK; Olson SB; Jones GR; Bagby GC
    Leukemia; 1999 Nov; 13(11):1784-9. PubMed ID: 10557053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of hemopoietic stem cells and progenitor cells in preleukemia].
    Dörmer P; Mergenthaler HG
    Verh Dtsch Ges Pathol; 1990; 74():65-74. PubMed ID: 1708637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myelodysplastic syndromes: mechanisms of transformation and neoplastic progression and their clinical implications].
    Cazzola M; Bergamaschi G; Bolis C; Ponchio L; Rosti V; Ascari E
    Haematologica; 1991 Jun; 76 Suppl 3():75-84. PubMed ID: 1752545
    [No Abstract]   [Full Text] [Related]  

  • 19. Clonal hematopoiesis and preleukemia-Genetics, biology, and clinical implications.
    Hartmann L; Metzeler KH
    Genes Chromosomes Cancer; 2019 Dec; 58(12):828-838. PubMed ID: 30939217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal evolutions during long-term cultures of bone marrow from de novo acute myeloid leukaemia with trilineage myelodysplasia and with myelodysplastic remission marrow.
    Tamura S; Kanamaru A; Takemoto Y; Kakishita E; Nagai K
    Br J Haematol; 1993 Jun; 84(2):219-26. PubMed ID: 8398821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.